Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00034125 |
Date of registration:
|
23/04/2002 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.
|
Scientific title:
|
a Phase 3 Randomized Double Blind Evaluation of LY353381 Compared With Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. |
Date of first enrolment:
|
April 2001 |
Target sample size:
|
|
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00034125 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
Phase:
|
Phase 3
|
|
Countries of recruitment
|
Argentina
|
Chile
|
India
|
Mexico
|
United States
| | | |
Key inclusion & exclusion criteria
|
Inclusion Criteria
1. Locally advanced or metastatic breast cancer
2. Bi-dimensionally measurable disease
Exclusion Criteria
1. Prior hormonal therapy
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Female
|
Health Condition(s) or Problem(s) studied
|
Breast Neoplasms
|
Intervention(s)
|
Drug: tamoxifen
|
Drug: LY353381
|
Secondary ID(s)
|
3883
|
H4Z-MC-JWXD
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|